Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention ...

Mainz Biomed (MYNZ) supports Colorectal Cancer Awareness Month in March. Detecting colorectal cancer in its early stages significantly improves ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the ...

Mr. Van Genderen has been with the company for five years, and most recently served as Chief Operating Officer and President ...